Surgery for distant melanoma metastasis

Cancer Journal

Volumn 18, Issue 2, 2012, Pages 176-184

  Leung, Anna M ^a   Hari, Danielle M ^a   Morton, Donald L ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

Stage IV melanoma; surgery; tumor doubling time

Indexed keywords

ALPHA INTERFERON; DACARBAZINE; INTERLEUKIN 2; IPILIMUMAB; PLACEBO; VEMURAFENIB;

ADRENAL CANCER; BRAIN METASTASIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLITIS; DISTANT METASTASIS; DRUG FATALITY; DRUG MECHANISM; HUMAN; IMMUNOTHERAPY; LIVER METASTASIS; LUNG EDEMA; LUNG METASTASIS; MELANOMA; METASTASIS RESECTION; PANCREAS CANCER; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; SHOCK; SPINAL CORD METASTASIS; SPLEEN CANCER; TREATMENT RESPONSE; VISCERAL METASTASIS;

CLINICAL TRIALS AS TOPIC; HUMANS; MELANOMA; NEOPLASM STAGING; RECURRENCE; SURVIVAL ANALYSIS;

EID: 84859461606     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0b013e31824bc981     Document Type: Review

References (66)

1. Thompson JF, Morton DL, Balch CM et al. Surgical excision of distant melanoma metastases. In: Balch CM, ed. Cutaneous Melanoma. St Louis, MO: Quality Medical Publishing; 2009.
2. Morton DL, Ollila DW, Hsueh EC, et al. Cytoreductive surgery and adjuvant immunotherapy: a new management paradigm for metastatic melanoma. CA Cancer J Clin. 1999;49:101-116. (Pubitemid 29353924)
3. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199-6206.
4. Coit DG, Andtbacka R, Bichakjian CK, et al. Melanoma. J Natl Compr Canc Netw. 2009;7:250-275.
5. Atkins MB, Hsu J, Lee S, et al. Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial coordinated by the Eastern Cooperative Oncology Group. J Clin Oncol. 2008;26:5748-5754.
6. Chapman PB, Hauschild A, Robert C, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011;364:2507-2516.
7. Hodi FS, O'Day SJ, McDermott DF, et al. Improved survival with ipili-mumab in patients with metastatic melanoma. N Engl J Med. 2010; 363:711-723.
8. Robert C, Thomas L, Bondarenko I, et al. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med. 2011; 364:2517-2526.
9. Trinh VA. Current management of metastatic melanoma. Am J Health Syst Pharm. 2008;65:S3-S8.
10. Atkins MB, Kunkel L, Sznol M, et al. High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival update. Cancer J Sci Am. 2000;6[suppl 1]:S11-S14.
11. Koyanagi K, Kuo C, Nakagawa T, et al. Multimarker quantitative real-time PCR detection of circulating melanoma cells in peripheral blood: relation to disease stage in melanoma patients. Clin Chem. 2005; 51:981-988. (Pubitemid 40740878)
12. Koyanagi K, Mori T, O'Day SJ, et al. Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients. Cancer Res. 2006;66:6111-6117.
13. Zetter BR. The cellular basis of site-specific tumor metastasis. N Engl J Med. 1990;322:605-612. (Pubitemid 20190796)
14. Barth A, Wanek LA, Morton DL. Prognostic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg. 1995;181:193-201.
15. Roth JA, Silverstein MJ, Morton DL. Metastatic potential of metastases. Surgery. 1976;79:669-673.
16. Hsueh EC, Gupta RK, Yee R, et al. Does endogenous immune response determine the outcome of surgical therapy for metastatic melanoma? Ann Surg Oncol. 2000;7:232-238. (Pubitemid 30215163)
17. Ollila DW, Hsueh EC, Stern SL, et al. Metastasectomy for recurrent stage IV melanoma. J Surg Oncol. 1999;71:209-213. (Pubitemid 29388015)
18. Gulec SA, Faries MB, Lee CC, et al. The role offluorine-18 deoxyglucose positron emission tomography in the management of patients with meta-static melanoma: impact on surgical decision making. Clin Nucl Med. 2003;28:961-965. (Pubitemid 38281828)
19. Meyer T, Merkel S, Goehl J, et al. Surgical therapy for distant metastases of malignant melanoma. Cancer. 2000;89:1983-1991.
20. Joseph WL, Morton DL, Adkins PC. Prognostic significance of tumor doubling time in evaluating operability in pulmonary metastatic disease. J Thorac Cardiovasc Surg. 1971;61:23-32.
21. Ollila DW, Stern SL, Morton DL. Tumor doubling time: a selection factor for pulmonary resection of metastatic melanoma. J Surg Oncol. 1998;69:206-211. (Pubitemid 29024563)
22. Wong JH, Skinner KA, Kim KA, et al. The role of surgery in the treatment of nonregionally recurrent melanoma. Surgery. 1993;113: 389-394. (Pubitemid 23111532)
23. Ollila DW. Complete metastasectomy in patients with stage IV metastatic melanoma. Lancet Oncol. 2006;7:919-924. (Pubitemid 44615951)
24. Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19: 3622-3634. (Pubitemid 32786275)
25. Tafra L, Dale PS, Wanek LA, et al. Resection and adjuvant immu-notherapy for melanoma metastatic to the lung and thorax. J Thorac Cardiovasc Surg. 1995;110:119-128; discussion 129.
26. Friedel G, Pastorino U, Buyse M, et al. Resection of lung metastases: long-term results and prognostic analysis based on 5206 casesVthe International Registry of Lung Metastases [in German]. Zentralbl Chir. 1999;124:96-103. (Pubitemid 29119011)
27. Caudle AS, Ross MI. Metastasectomy for stage IV melanoma: for whom and how much? Surg Oncol Clin N Am. 2011;20:133-144.
28. Harpole DH Jr, Johnson CM, Wolfe WG, et al. Analysis of 945 cases of pulmonary metastatic melanoma. J Thorac Cardiovasc Surg. 1992;103: 743-748;discussion 748-750.
29. Koyi H, Branden E. Intratracheal metastasis from malignant melanoma. J Eur Acad Dermatol Venereol. 2000;14:407-408. (Pubitemid 32898898)
30. Ollila DW, Essner R, Wanek LA, et al. Surgical resection for melanoma metastatic to the gastrointestinal tract. Arch Surg. 1996;131:975-979; 979-980.
31. Amersi FF, Terando AM, Goto Y, et al. Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine. Clin Cancer Res. 2008;14:638-645. (Pubitemid 351231142)
32. Gutman H, Hess KR, Kokotsakis JA, et al. Surgery for abdominal me-tastases of cutaneous melanoma. World J Surg. 2001;25:750-758. (Pubitemid 32531922)
33. Rose DM, Essner R, Hughes TM, et al. Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg. 2001;136:950-955. (Pubitemid 32729559)
34. Foster JH. Survival after liver resection for secondary tumors. Am J Surg. 1978;135:389-394. (Pubitemid 8298456)
35. Iwatsuki S, Esquivel CO, Gordon RD, et al. Liver resection for metastatic colorectal cancer. Surgery. 1986;100:804-810. (Pubitemid 16008854)
36. Papachristou DN, Fortner JJ. Surgical treatment of metastatic melanoma confined to the liver. Int Surg. 1983;68:145-148. (Pubitemid 13051543)
37. Ekberg H, Tranberg KG, Andersson R, et al. Major liver resection: perioperative course and management. Surgery. 1986;100:1-8. (Pubitemid 16037574)
38. Olak J, Wexler MJ, Rodriguez J, et al. Hepatic resection for metastatic disease. Can J Surg. 1986;29:435-439. (Pubitemid 17186866)
39. Stehlin JS Jr, de Ipolyi PD, Greeff PJ, et al. Treatment of cancer of the liver. Twenty years' experience with infusion and resection in 414 patients. Ann Surg. 1988;208:23-35.
40. Wolf RF, Goodnight JE, Krag DE, et al. Results of resection and proposed guidelines for patient selection in instances of non-colorectal hepatic metastases. Surg Gynecol Obstet. 1991;173:454-460.
41. Karakousis CP, Velez A, Driscoll DL, et al. Metastasectomy in malignant melanoma. Surgery. 1994;115:295-302. (Pubitemid 24098320)
42. Harrison LE, Brennan MF, Newman E, et al. Hepatic resection for non-colorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery. 1997;121:625-632. (Pubitemid 27251901)
43. Lindell G, Ohlsson B, Saarela A, et al. Liver resection of noncolorectal secondaries. J Surg Oncol. 1998;69:66-70. (Pubitemid 28515962)
44. Elias D, Cavalcanti de Albuquerque A, Eggenspieler P, et al. Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients. J Am Coll Surg. 1998;187: 487-493. (Pubitemid 28506854)
45. Lang H, Nussbaum KT, Weimann A, et al. Liver resection for non-colorectal, non-neuroendocrine hepatic metastases [in German]. Chirurg. 1999;70:439-446.
46. Wood TF, DiFronzo LA, Rose DM, et al. Does complete resection of melanoma metastatic to solid intra-abdominal organs improve survival? Ann Surg Oncol. 2001;8:658-662. (Pubitemid 32847931)
47. Sampson JH, Carter JH Jr, Friedman AH, et al. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg. 1998;88:11-20. (Pubitemid 28018958)
48. Fife KM, Colman MH, Stevens GN, et al. Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol. 2004;22: 1293-1300. (Pubitemid 41079844)
49. Feun LG, Gutterman J, Burgess MA, et al. The natural history of rese-ctable metastatic melanoma (stage IVA melanoma). Cancer. 1982;50: 1656-1663. (Pubitemid 12034567)
50. Coffey RJ, Flickinger JC, Bissonette DJ, et al. Radiosurgery for solitary brain metastases using the cobalt-60 gamma unit: methods andresults in 24 patients. Int J Radiat Oncol Biol Phys. 1991;20:1287-1295.
51. Somaza S, Kondziolka D, Lunsford LD, et al. Stereotactic radiosurgery for cerebral metastatic melanoma. J Neurosurg. 1993;79:661-666. (Pubitemid 23320882)
52. Lavine SD, Petrovich Z, Cohen-Gadol AA, et al. Gamma knife radio-surgery for metastatic melanoma: an analysis of survival, outcome, and complications. Neurosurgery. 1999;44:59-64; discussion 64-66.
53. Gokaslan ZL, Aladag MA, Ellerhorst JA. Melanoma metastatic to the spine: a review of 133 cases. Melanoma Res. 2000;10:78-80. (Pubitemid 30127832)
54. Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet. 2005;366:643-648. (Pubitemid 41176016)
55. Wasif N, Bagaria SP, Ray P, et al. Does metastasectomy improve survival in patients with stage IV melanoma? A cancer registry analysis of outcomes. J Surg Oncol. 2011;104:111-115.
56. Morton DL, Mozzillo N, Thompson JA, et al. An international, randomized, double-blind, phase 3 study of the specific active immu-notherapy agent, Onamelatucel-L (Canvaxin), compared to placebo as a post-surgical adjuvant in AJCC stage IV melanoma. Ann Surg Oncol. 2006;13:5.
57. Sosman JA, Moon J, Tuthill RJ, et al. A phase 2 trial of complete resection for stage IV melanoma: Results of Southwest Oncology Group Clinical Trial S9430. Cancer. 2011;117:4740-4746.
58. Morton DL, Mozzillo N, Thompson JF, et al. An international, randomized, phase III trial of Bacillus Calmette-Guérin (BCG) plus allo-geneic melanoma vaccine (MCV) or placebo after complete resection of melanoma metastatic to regional or distant sites. J Clin Oncol. 2007;25:Abstract 8508.
59. Faries MB, Morton DL. Melanoma: is immunotherapy of benefit? Adv Surg. 2003;37:139-169. (Pubitemid 40745663)
60. Eton O, Legha SS, Moon TE, et al. Prognostic factors for survival of patients treated systemically for disseminated melanoma. J Clin Oncol. 1998;16:1103-1111. (Pubitemid 28108747)
61. Petersen RP, Hanish SI, Haney JC, et al. Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma. J Thorac Cardiovasc Surg. 2007;133:104-110.
62. Andrews S, Robinson L, Cantor A, et al. Survival after surgical resection of isolated pulmonary metastases from malignant melanoma. Cancer Control. 2006;13:218-223. (Pubitemid 44469743)
63. Leo F, Cagini L, Rocmans P, et al. Lung metastases from melanoma: when is surgical treatment warranted? Br J Cancer. 2000;83:569-572. (Pubitemid 30636294)
64. Mittendorf EA, Lim SJ, Schacherer CW, et al. Melanoma adrenal metastasis: natural history and surgical management. Am J Surg. 2008;195: 363-369; discussion 368-369. (Pubitemid 351625119)
65. Collinson FJ, Lam TK, Bruijn WM, et al. Long-term survival and occasional regression of distant melanoma metastases after adrenal metas-tasectomy. Ann Surg Oncol. 2008;15:1741-1749. (Pubitemid 351668157)
66. Neuman HB, Patel A, Hanlon C, et al. Stage-IV melanoma and pulmonary metastases: factors predictive of survival. Ann Surg Oncol. 2007; 14:2847-2853. (Pubitemid 47460630)